# VYNE (Yarrow Bioscience, Inc.) - SEC EDGAR Financial Statements

> Yarrow Bioscience, Inc. reported $570K in revenue and a net loss of $26.48M for the fiscal year ended December 31, 2025 (up 13.8% year over year), with a -5219.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/VYNE
- Markdown: https://convexityos.com/fundamentals/VYNE.md
- SEC CIK: 0001566044
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:47 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001566044&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $570K | +13.8% YoY |
| Operating Income | FY 2025 | -$29.75M | -5219.1% margin |
| Net Income | FY 2025 | -$26.48M | -4646.1% net margin |
| Diluted EPS | FY 2025 | -$31.00 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$33.12M | -5811.2% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $268.9M | Total debt: $0 |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $570K | $501K | $424K | $477K | $931K | $20.99M | $0 | $0 | $4.58M | $674K |
| Cost of Revenue | -- | -- | -- | -- | $3.35M | $1.39M | $0 | $0 | -- | -- |
| **Gross Profit** | -- | -- | -- | -- | -$2.42M | $19.60M | $0 | $0 | -- | -- |
| Research & Development | $19.24M | $30.95M | $16.31M | $18.39M | $19.54M | $43.53M | $51.20M | $64.47M | $29.01M | $11.26M |
| Selling, General & Admin | -- | -- | -- | $16.39M | $20.30M | $89.54M | $45.11M | $14.01M | -- | -- |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | $76.24M | $65.17M | $34.17M | $15.01M |
| **Operating Income** | -$29.75M | -$43.64M | -$29.26M | -$34.30M | -$38.91M | -$252.5M | -$95.87M | -$74.89M | -$29.59M | -$14.33M |
| **EBITDA** | -$29.73M | -$43.63M | -$29.26M | -$34.22M | -$38.80M | -$252.2M | -$95.52M | -$74.57M | -- | -- |
| Interest Expense | -- | -- | -- | $0 | $5.61M | $4.39M | $921K | $0 | -- | -- |
| Income Before Tax | -$26.73M | -$39.80M | -$27.87M | -$33.93M | -$44.66M | -$255.8M | -$95.35M | -$73.95M | -- | -- |
| Income Tax Expense | $4.0K | $4.0K | $0 | $13K | -$448K | -$258K | -$176K | $212K | $0 | -- |
| **Net Income** | -$26.48M | -$39.83M | -$28.45M | -$23.21M | -$73.33M | -$255.6M | -$95.18M | -$74.16M | -$29.08M | -$14.07M |
| Basic EPS | -$31.00 | -$46.50 | -$139.00 | -$364.00 | -$23,057.55 | $7,086.33 | $40,359.71 | $41,258.99 | -$20,467.63 | -$10,143.88 |
| **Diluted EPS** | -$31.00 | -$46.50 | -$139.00 | -$364.00 | -$23,057.55 | $7,086.33 | $40,359.71 | $41,258.99 | -$20,467.63 | -$10,143.88 |
| Basic Shares Outstanding | 855.4K | 851.8K | 205.5K | 63.7K | 3.2K | 36.0K | 2.4K | 1.8K | 1.4K | 1.4K |
| Diluted Shares Outstanding | 855.4K | 851.8K | 205.5K | 63.7K | 3.2K | 36.0K | 2.4K | 1.8K | 1.4K | 1.4K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | $97K | $86K | $69K | $202K | $84K | $121K | $198K |
| Research & Development | $5.28M | $788K | $817K | $4.88M | $6.12M | $9.68M | $10.25M | $7.31M |
| **Operating Income** | -$10.74M | -$3.10M | -$3.82M | -$7.54M | -$9.20M | -$12.77M | -$13.09M | -$10.40M |
| **EBITDA** | -$10.75M | -$3.10M | -$3.81M | -$7.54M | -$9.19M | -- | -- | -$10.40M |
| Income Before Tax | -- | -$2.90M | -$3.58M | -$5.75M | -$8.60M | -$12.01M | -$12.16M | -$9.39M |
| Income Tax Expense | -- | $0 | $0 | $0 | $0 | $4.0K | $0 | $0 |
| **Net Income** | -$9.72M | -$6.51M | -$2.75M | -$5.75M | -$8.61M | -$12.02M | -$12.16M | -$9.41M |
| Basic EPS | -$0.43 | -$3.51 | -$4.00 | -$6.73 | -$10.00 | -- | -$14.50 | -$11.00 |
| **Diluted EPS** | -$0.43 | -$3.51 | -$4.00 | -$6.73 | -$10.00 | -- | -$14.50 | -$11.00 |
| Basic Shares Outstanding | 22.6M | 858.0K | 855.4K | 855.0K | 853.5K | -- | 851.7K | 851.7K |
| Diluted Shares Outstanding | 22.6M | 858.0K | 855.4K | 855.0K | 853.5K | -- | 851.7K | 851.7K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $99.99M | $19.93M | $30.62M | $30.91M | $42.25M | $57.56M | $43.76M | $27.87M | $10.21M | $4.03M |
| Short-Term Investments | $4.98M | $41.59M | $62.63M | $0 | $0 | $1.03M | $16.68M | $86.74M | $49.30M | $26.88M |
| **Cash & Short-Term Investments** | $105.0M | $61.52M | $93.25M | $31.00M | $42.90M | $59.40M | $60.44M | $136.2M | $59.50M | $30.91M |
| Accounts Receivable, Net | -- | -- | -- | $173K | $7.58M | $15.82M | $135K | -- | $786K | $0 |
| Inventory | -- | -- | -- | -- | $7.29M | $7.40M | $1.36M | -- | -- | -- |
| **Total Current Assets** | $100.0M | $64.44M | $95.96M | $38.27M | $63.19M | $87.26M | $76.41M | $139.5M | $63.86M | $31.54M |
| Property, Plant & Equipment, Net | $0 | $113K | $0 | $0 | $354K | $555K | $2.88M | $146K | $28K | $27K |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | -- | -- | $2.98M | $10.42M |
| Other Non-Current Assets | $407K | -- | -- | -- | -- | $4.34M | $166K | -- | $0 | -- |
| **Total Non-Current Assets** | $407K | $2.47M | $1.72M | $2.48M | $3.86M | $6.48M | $4.75M | $428K | $3.01M | $10.51M |
| **Total Assets** | $100.4M | $66.91M | $97.69M | $40.76M | $67.05M | $93.74M | $81.16M | $139.9M | $66.87M | $42.05M |
| Accounts Payable | $1.53M | $2.71M | $1.66M | $2.39M | $6.51M | $4.78M | $3.77M | $3.29M | $2.46M | $1.53M |
| Short-Term Debt | -- | -- | -- | -- | -- | $0 | -- | -- | -- | -- |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | -- | $1.80M | $1.80M |
| Other Current Liabilities | $0 | $1.31M | $0 | -- | $0 | $104K | $270K | -- | -- | -- |
| **Total Current Liabilities** | $71.55M | $14.82M | $7.54M | $9.35M | $18.41M | $21.77M | $29.33M | $9.54M | $7.82M | $3.90M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $33.17M | $32.73M | -- | -- | -- |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | -- | $6.74M | $8.53M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $7.0K | $22K | $57K |
| **Total Non-Current Liabilities** | $0 | $0 | $1.41M | $0 | $0 | $34.48M | $34.26M | $7.0K | $6.76M | $8.59M |
| **Total Liabilities** | $71.55M | $14.82M | $8.95M | $9.35M | $18.41M | $56.25M | $63.58M | $9.55M | $14.57M | $12.49M |
| **Total Debt (incl. Leases)** | $0 | $99K | $214K | $0 | $349K | $34.78M | $34.47M | -- | -- | -- |
| Common Stock | $0 | $1.0K | $1.0K | $0 | $5.0K | $4.0K | $1.0K | $3.0K | $1.0K | $1.0K |
| Retained Earnings | -$70.99M | -$731.2M | -$691.3M | -$662.7M | -$639.5M | -$566.2M | -$310.6M | -$110.6M | -$59.19M | -$30.11M |
| Accumulated Other Comp. Income | $2.0K | $20K | $26K | $0 | $0 | $0 | $5.0K | -$96K | -$51K | -$26K |
| **Total Stockholders' Equity** | -$70.99M | $52.09M | $88.73M | $31.20M | $48.64M | $37.49M | $17.57M | $92.18M | $68.60M | -$29.44M |
| Total Equity | -$70.99M | $52.09M | $88.73M | $31.20M | $48.64M | $37.49M | $17.57M | $92.18M | $68.60M | -$29.44M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $268.9M | $22.93M | $24.63M | $99.99M | $22.05M | $28.21M | $19.93M | $16.27M |
| Short-Term Investments | -- | $0 | $297K | $4.98M | $17.60M | $22.06M | $41.59M | $53.91M |
| **Cash & Short-Term Investments** | $268.9M | $22.93M | $24.93M | $105.0M | $39.65M | $50.27M | $61.52M | $70.19M |
| **Total Current Assets** | $274.0M | $23.53M | $25.79M | $100.0M | $44.34M | $54.91M | $64.44M | $73.53M |
| Property, Plant & Equipment, Net | $72K | $78K | $84K | $0 | $102K | $107K | $113K | -- |
| Other Non-Current Assets | $0 | -- | -- | $407K | -- | -- | -- | -- |
| **Total Non-Current Assets** | $72K | $78K | $84K | $407K | $375K | $1.51M | $2.47M | $2.66M |
| **Total Assets** | $274.0M | $23.60M | $25.87M | $100.4M | $44.72M | $56.42M | $66.91M | $76.20M |
| Accounts Payable | $2.13M | $614K | $261K | $1.53M | $1.41M | $3.53M | $2.71M | $3.99M |
| Other Current Liabilities | -- | -- | -- | $0 | $0 | $1.31M | $1.31M | $1.31M |
| **Total Current Liabilities** | $6.51M | $1.54M | $1.24M | $71.55M | $5.84M | $12.29M | $14.82M | $12.66M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $6.51M | $1.54M | $1.24M | $71.55M | $5.84M | $12.29M | $14.82M | $12.66M |
| **Total Debt (incl. Leases)** | $0 | $0 | $0 | $0 | $25K | $63K | $99K | $123K |
| Common Stock | $1.0K | $0 | $3.0K | $0 | $2.0K | $2.0K | $1.0K | $1.0K |
| Retained Earnings | -$89.97M | -$764.2M | -$761.2M | -$70.99M | -$745.5M | -$739.8M | -$731.2M | -$719.1M |
| Accumulated Other Comp. Income | -- | $0 | $0 | $2.0K | -$2.0K | $0 | $20K | $34K |
| **Total Stockholders' Equity** | $267.5M | -$79.43M | -$73.43M | -$70.99M | $38.88M | $44.13M | $52.09M | $63.54M |
| Total Equity | $267.5M | -$79.43M | -$73.43M | -$70.99M | $38.88M | $44.13M | $52.09M | $63.54M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$26.48M | -$39.83M | -$28.45M | -$23.21M | -$73.33M | -$255.6M | -$95.18M | -$74.16M | -$29.08M | -$14.07M |
| Depreciation & Amortization | $23K | $4.0K | $0 | $72K | $109K | $341K | $350K | $319K | -- | -- |
| Stock-Based Compensation | $2.31M | $3.30M | $3.31M | $4.30M | $8.08M | $18.10M | $4.89M | $5.32M | $5.32M | $573K |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | $786K | -$786K | $0 |
| Change in Inventory | -- | -- | $0 | $97K | $113K | -$6.05M | -$1.36M | $0 | -- | -- |
| Change in Payables | -- | -- | -- | -- | -- | -- | $481K | $825K | $620K | $889K |
| **Operating Cash Flow** | -$33.12M | -$33.97M | -$25.34M | -$29.20M | -$56.37M | -$137.1M | -$73.39M | -$68.66M | -$28.22M | -$2.27M |
| Capital Expenditure | $0 | -$117K | $0 | -- | $0 | -$113K | -$1.06M | -$567K | -$27K | -$31K |
| **Free Cash Flow** | -$33.12M | -$34.09M | -$25.34M | -- | -$56.37M | -$137.2M | -$74.45M | -$69.23M | -$28.25M | -$2.30M |
| Purchases of Investments | -$30.93M | -$60.52M | -$62.35M | $0 | -- | $0 | -$83.40M | -$126.7M | -$64.15M | -$55.31M |
| Sales & Maturities of Investments | -- | -- | -- | -- | -- | -- | $124.8M | $92.96M | $49.09M | -- |
| **Investing Cash Flow** | $37.37M | $23.36M | -$57.35M | $15.67M | $1.03M | $89.11M | $41.87M | -$11.76M | -$15.09M | -$37.52M |
| Common Stock Issued | -- | -- | -- | $1.47M | $75.98M | $61.64M | $13.71M | $91.49M | -- | -- |
| **Financing Cash Flow** | -$143K | -$141K | $82.39M | $1.65M | $39.78M | $61.81M | $47.95M | $92.37M | $49.49M | $0 |
| **Net Change in Cash** | $4.10M | -$10.75M | -$301K | -$11.88M | -$15.56M | $13.83M | -$18.73M | $39.30M | $6.18M | -$39.78M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$9.72M | -$6.51M | -$2.75M | -$5.75M | -$8.61M | -$12.02M | -$12.16M | -$9.41M |
| Depreciation & Amortization | -$8.0K | $6.0K | $6.0K | $6.0K | $6.0K | -- | -- | $0 |
| Stock-Based Compensation | $608K | $436K | $474K | $529K | $763K | $699K | $734K | $885K |
| **Operating Cash Flow** | -$89.96M | -$1.99M | -$4.08M | -$10.80M | -$11.46M | -$9.00M | -$8.51M | -$8.48M |
| Purchases of Investments | -- | $0 | $0 | -$9.57M | -$13.77M | -$10.04M | -$28.42M | -$6.88M |
| **Investing Cash Flow** | -- | $300K | $4.70M | $4.67M | $19.83M | $12.74M | -$4.82M | $19.02M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | $0 | $0 |
| **Financing Cash Flow** | $265.0M | -$14K | -$15K | -$34K | -$87K | -$132K | -$2.0K | -$2.0K |
| **Net Change in Cash** | $170.1M | -$1.71M | $604K | -$6.16M | $8.28M | $3.61M | -$13.34M | $10.54M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -259.6% | 93.4% | -- | -- | -- | -- |
| **Operating Margin** | -5219.1% | -8710.0% | -6900.5% | -7189.7% | -4179.5% | -1203.0% | -- | -- | -645.9% | -2126.4% |
| **Net Profit Margin** | -4646.1% | -7950.9% | -6710.4% | -4865.8% | -7876.4% | -1217.4% | -- | -- | -634.6% | -2087.2% |
| Return on Equity (ROE) | -- | -76.5% | -32.1% | -74.4% | -150.8% | -681.6% | -541.6% | -80.5% | -42.4% | -- |
| Return on Assets (ROA) | -26.4% | -59.5% | -29.1% | -56.9% | -109.4% | -272.6% | -117.3% | -53.0% | -43.5% | -33.5% |
| Current Ratio | 1.40x | 4.35x | 12.73x | 4.10x | 3.43x | 4.01x | 2.61x | 14.62x | 8.17x | 8.08x |
| Quick Ratio | 1.47x | 4.15x | 12.37x | 3.34x | 3.04x | 3.67x | 2.56x | 14.28x | 7.71x | 7.92x |
| Debt to Equity | -- | 0.00x | 0.00x | 0.00x | 0.01x | 0.93x | 1.96x | -- | -- | -- |
| **Revenue Growth (YoY)** | +13.8% | +18.2% | -11.1% | -48.8% | -95.6% | -- | -- | -100.0% | +579.8% | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -112.3% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -425.4% | -82.4% | -2.2% | -- | -- | -- |
| 5Y Revenue / Share Growth | -99.9% | -- | -- | -99.8% | -39.8% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -8949.6% | -7513.1% | -8710.0% | -7646.9% | -6346.1% |
| **Net Profit Margin** | -- | -- | -- | -8097.7% | -6974.5% | -7950.9% | -6896.6% | -5849.2% |
| Return on Equity (ROE) | -- | -- | -- | -99.1% | -95.6% | -76.5% | -53.5% | -38.0% |
| Return on Assets (ROA) | -- | -- | -- | -86.2% | -74.8% | -59.5% | -44.6% | -32.8% |
| Current Ratio | 42.08x | 15.26x | 20.86x | 7.60x | 4.47x | 4.35x | 5.81x | 7.13x |
| Quick Ratio | 41.29x | 14.87x | 20.17x | 6.79x | 4.09x | 4.15x | 5.54x | 6.64x |
| Debt to Equity | 0.00x | -- | -- | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| **Revenue Growth (YoY)** | -- | +40.6% | -57.4% | -65.2% | +106.1% | +10.5% | +6.1% | +46.7% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
